Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02470910
What this trial is testing

Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning

Who this might be right for
Prostate CancerAdenocarcinoma of the Prostate Stage IAdenocarcinoma of the Prostate Stage II+1 more
Dana-Farber Cancer Institute 15
Early research (Phase 1)Study completedNCT00004928
What this trial is testing

Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00087139
What this trial is testing

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 124
Not applicableStudy completedNCT02830165
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

Who this might be right for
Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7Stage II Prostate Adenocarcinoma AJCC v7Stage III Prostate Adenocarcinoma AJCC v7
Jonsson Comprehensive Cancer Center 11
Not applicableActive Not RecruitingNCT04985565
What this trial is testing

Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+4 more
M.D. Anderson Cancer Center 12
Early research (Phase 1)Study completedNCT00305747
What this trial is testing

Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 12
Not applicableUnknownNCT01177865
What this trial is testing

Study of Treatment Choice in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University College London Hospitals 432
Testing effectiveness (Phase 2)Looking for participantsNCT06683846
What this trial is testing

Ivonescimab in the Treatment of Multiple Advanced Tumors

Who this might be right for
Pheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more
Fudan University 400
Early research (Phase 1)Study completedNCT00099086
What this trial is testing

Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 20
Testing effectiveness (Phase 2)Ended earlyNCT01126879
What this trial is testing

Genistein in Treating Patients With Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+2 more
Northwestern University 12
Testing effectiveness (Phase 2)Study completedNCT03406858
What this trial is testing

Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaProstate Carcinoma Metastatic in the Bone+2 more
Barbara Ann Karmanos Cancer Institute 15
Early research (Phase 1)Study completedNCT01028885
What this trial is testing

MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateStage I Prostate Cancer+2 more
Abramson Cancer Center at Penn Medicine 10
Not applicableActive Not RecruitingNCT02176902
What this trial is testing

Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage I Prostate CancerStage IIA Prostate Cancer+1 more
Jonsson Comprehensive Cancer Center 107
Testing effectiveness (Phase 2)Study completedNCT00081172
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04037254
What this trial is testing

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

Who this might be right for
Prostate AdenocarcinomaStage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+4 more
NRG Oncology 22
Large-scale testing (Phase 3)Looking for participantsNCT07426055
What this trial is testing

PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate BrachytherapyStereotactic Body Radiation Therapy (SBRT)+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Testing effectiveness (Phase 2)Study completedNCT01075308
What this trial is testing

SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 32
Early research (Phase 1)Study completedNCT00082732
What this trial is testing

Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 56
Testing effectiveness (Phase 2)Study completedNCT00093457
What this trial is testing

Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 28
Large-scale testing (Phase 3)Study completedNCT03274687
What this trial is testing

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7+1 more
NRG Oncology 296
Next Page